文献速递妇产影像US

丹麦子痫前期筛查(PRESIDE):全国验证研究

Pre-eclampsia screening in Denmark (PRESIDE): national validation study.
PubMed 文献 · Ultrasound Obstet Gynecol · 2023-05-05

这项前瞻性多中心研究在丹麦6所大学医院纳入8783名单胎孕妇,评估FMF早孕期子痫前期筛查算法在丹麦人群的预测性能,并与现行基于母体风险因素的策略比较。结果显示,在10%筛查阳性率下,FMF算法对<34周和<37周子痫前期的检出率分别为77.4%和66.8%,优于现行策略。

要点

  • FMF算法在10%筛查阳性率下对早产子痫前期检出率较高。
  • 现行丹麦策略在3.4%筛查阳性率下检出率较低。
  • 联合母体特征、MAP、UtA-PI、PlGF和PAPP-A可提高预测性能。

诊断标准与关键数值

  • FMF算法在10%筛查阳性率下,对<34周子痫前期检出率为77.4%(95% CI 57.6-97.2%),对<37周为66.8%(95% CI 54.4-79.1%),对任何孕周为44.1%(95% CI 38.5-49.7%)。
  • 现行丹麦策略在3.4%筛查阳性率下,对<34周子痫前期检出率为25.0%,对<37周为19.6%。
  • FMF算法(母体特征、MAP、UtA-PI和PlGF)在固定3.4%筛查阳性率下,对<34周子痫前期检出率为60.5%(95% CI 36.9-84.1%),对<37周为45.2%(95% CI 32.0-58.5%)。

局限性

  • 研究为丹麦单国多中心设计,结果外推需谨慎。
  • 完整风险评估数据仅覆盖92.9%的纳入孕妇。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the predictive performance of the Fetal Medicine Foundation (FMF) first-trimester screening algorithm for pre-eclampsia in a Danish population and compare screening performance with that of the current Danish strategy, which is based on maternal risk factors.

METHODS: This was a prospective study of women with a singleton pregnancy attending for their first-trimester ultrasound scan and screening for aneuploidies at six Danish university hospitals between May 2019 and December 2020. Prenatal data on maternal characteristics and medical history were recorded, and measurements of mean arterial pressure (MAP), uterine artery pulsatility index (UtA-PI), serum pregnancy-associated plasma protein-A (PAPP-A) and serum placental growth factor (PlGF) were collected without performing a risk assessment for pre-eclampsia. Information on acetylsalicylic acid use was recorded. After delivery, pregnancy outcome, including gestational age at delivery and pre-eclampsia diagnosis, was recorded. Pre-eclampsia risk assessment for each woman was calculated blinded to outcome using the FMF screening algorithm following adjustment to the Danish population. Detection rates (DRs) of the FMF algorithm were calculated for a fixed screen-positive rate (SPR) of 10% and for the SPR achieved in the current Danish screening.

RESULTS: A total of 8783 pregnant women were included, with a median age of 30.8 (interquartile range (IQR), 28.1-33.9) years. The majority were white (95%), naturally conceiving (90%), non-smokers (97%) and had no family history of pre-eclampsia (96%). The median body mass index was 23.4 (IQR, 21.2-26.6) kg/m2 . A complete risk assessment including maternal characteristics, MAP, UtA-PI, PlGF and PAPP-A was available for 8156 women (92.9%). In these women, UtA-PI was measured bilaterally with a median value of 1.58 (IQR, 1.27-1.94) and the median resting MAP of 80.5 (IQR, 76.1-85.4) mmHg in two consecutive measurements. Among these, 303 (3.7%) developed pre-eclampsia, including 55 (0.7%) cases of pre-eclampsia with delivery < 37 weeks of gestation and 16 (0.2%) cases of pre-eclampsia with delivery < 34 weeks. At a SPR of 10%, combined screening using the FMF algorithm based on maternal characteristics, MAP, UtA-PI, PlGF and PAPP-A had a DR of 77.4% (95% CI, 57.6-97.2%) for pre-eclampsia with delivery < 34 weeks, 66.8% (95% CI, 54.4-79.1%) for pre-eclampsia with delivery < 37 weeks and 44.1% (95% CI, 38.5-49.7%) for pre-eclampsia with delivery at any gestational age. The current Danish screening strategy using maternal risk factors detected 25.0% of women with pre-eclampsia with delivery < 34 weeks and 19.6% of women with pre-eclampsia with delivery < 37 weeks at a SPR of 3.4%. When applying the FMF algorithm including maternal characteristics, MAP, UtA-PI and PlGF at the fixed SPR of 3.4%, the DRs were 60.5% (95% CI, 36.9-84.1%) for PE with delivery < 34 weeks and 45.2% (95% CI, 32.0-58.5%) for PE with delivery < 37 weeks.

CONCLUSION: In this large Danish multicenter study, the FMF algorithm based on maternal characteristics, MAP, UtA-PI, PlGF and PAPP-A predicted 77.4% of cases with pre-eclampsia with delivery < 34 weeks and 66.8% of cases with pre-eclampsia with delivery < 37 weeks of gestation at a SPR of 10%, suggesting that the performance of the algorithm in a Danish cohort matches that in other populations. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Riishede, Rode, Sperling, et al. Pre-eclampsia screening in Denmark (PRESIDE): national validation study. Ultrasound Obstet Gynecol. 2023. PMID: 36840981. doi:10.1002/uog.26183

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。